Immune checkpoint blockade (ICB) therapy is a powerful option for cancer treatment. Despite demonstrable progress, most patients fail to respond or achieve durable responses …
X Liu, J Yao, Y Zhao, J Wang, H Qi - Nature immunology, 2022 - nature.com
Durable antibody immunity depends on long-lived plasma cells (LLPCs) that primarily reside in the bone marrow (BM). However, due to LLPC rarity, it has not been possible to define …
R Raue, AC Frank, DC Fuhrmann, P de la Cruz-Ojeda… - Biology, 2022 - mdpi.com
Simple Summary The tumor microenvironment determines the prognosis and outcome for cancer patients. Herein, tumor-associated macrophages are not only highly abundant, but …
miRNAs are 20–22 long nucleotide non-coding ribonucleic acid molecules critical to the modulation of molecular pathways. Immune evasion and the establishment of a suitable …
G St-Cyr, D Penarroya, L Daniel, H Giguère… - Frontiers in …, 2023 - frontiersin.org
MiRNAs (miRNA, miR) play important functions in the tumor microenvironment (TME) by silencing gene expression through RNA interference. They are involved in regulating both …
B Chen, Y Li, H Wang - Nanotechnology Reviews, 2024 - degruyter.com
Immunotherapy is currently the main treatment for malignant tumors by activating immune cell. Metabolic reprogramming in tumor microenvironment can greatly affect the function of …
D Slavkovic-Lukic, J Fioravanti, A Martín-Santos… - … : Methods and Protocols, 2023 - Springer
The functional fitness of CAR T cells plays a crucial role in determining their clinical efficacy. Several strategies are being explored to increase cellular fitness, but screening these …
Generating T-cell receptors (TCRs) with desired epitope-binding properties is a fundamental step in the development of immunotherapies, yet heavily relies on laborious and expensive …